Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer

BMC Cancer. 2024 Mar 25;24(1):378. doi: 10.1186/s12885-024-12150-8.

Weiwei Huang^#^{1

2

3}, Chenxi Wang^#⁴, Yangkun Shen⁴, Qi Chen⁴, Zhijian Huang⁵, Jian Liu², Xiaoyan Lin^{6

7}, Lili Wang², Fan Wu², Xinhua Chen², Nani Li², Yi Hong², Mulan Chen², Jieyu Li⁸, Chuanzhong Huang⁸

¹ Department of Medical Oncology, Fujian Medical University Union Hospital, No.29, Xinquan Road, Gulou District, 350001, Fuzhou, Fujian province, China.
² Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, 350014, Fuzhou, Fujian province, China.
³ Fujian Key Laboratory of Translational Cancer Medicine, Fujian Cancer Hospotial, No.91, Fuma Road, Jin'an District, 350014, Fuzhou, Fujian province, China.
⁴ Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Fujian Normal University Qishan Campus, 350117, College Town, Fuzhou, Fujian Province, PR China.
⁵ Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 91, Fuma Road, Jin'an District, 350014, Fuzhou, Fujian province, China.
⁶ Department of Medical Oncology, Fujian Medical University Union Hospital, No.29, Xinquan Road, Gulou District, 350001, Fuzhou, Fujian province, China. 0591linxiaoyan@sina.com.
⁷ Fujian Key Laboratory of Translational Cancer Medicine, Fujian Cancer Hospotial, No.91, Fuma Road, Jin'an District, 350014, Fuzhou, Fujian province, China. 0591linxiaoyan@sina.com.
⁸ Laboratory of Immuno-Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No.91, Fuma Road, Jin'an District, 350014, Fuzhou, Fujian province, China.

^# Contributed equally.

No abstract available

Publication types